Review
doi: 10.1097/MAJ.0b013e3181e939ab.
Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections
Affiliations
- PMID: 20697258
- PMCID: PMC2935929
- DOI: 10.1097/MAJ.0b013e3181e939ab
Item in Clipboard
Review
Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections
Am J Med Sci.
2010 Sep.
Abstract
Infections caused by virulent Gram-positive bacteria, such as Staphylococcus aureus, group B streptococci and group A streptococci, remain significant causes of morbidity and mortality despite progress in antimicrobial therapy. Despite significant advances in the understanding of the pathogenesis of infection caused by these organisms, there are only limited strategies to prevent infection. In this article, we review efforts to develop safe and effective vaccines that would prevent infections caused by these 3 pathogens.
Similar articles
-
Polysaccharide conjugate vaccines for the prevention of gram-positive bacterial infections.Adv Exp Med Biol. 1996;397:133-40. doi: 10.1007/978-1-4899-1382-1_18. Adv Exp Med Biol. 1996. PMID: 8718592 Review. No abstract available.
-
Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens.BMC Microbiol. 2024 Jul 27;24(1):280. doi: 10.1186/s12866-024-03427-w. BMC Microbiol. 2024. PMID: 39068414 Free PMC article.
-
Invasive gram-positive bacterial infection in cancer patients.Clin Infect Dis. 2014 Nov 15;59 Suppl 5(Suppl 5):S331-4. doi: 10.1093/cid/ciu598. Clin Infect Dis. 2014. PMID: 25352626 Free PMC article. Review.
-
Rationale for the development of immunotherapy regimens against enterococcal infections.Vaccine. 2004 Dec 6;22 Suppl 1:S31-8. doi: 10.1016/j.vaccine.2004.08.014. Vaccine. 2004. PMID: 15576199 Review.
-
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci.Drugs. 1996;51 Suppl 1:6-12. doi: 10.2165/00003495-199600511-00004. Drugs. 1996. PMID: 8724811 Review.
Cited by
-
Structural vaccinology to thwart antigenic variation in microbial pathogens.Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10029-30. doi: 10.1073/pnas.1107324108. Epub 2011 Jun 13. Proc Natl Acad Sci U S A. 2011. PMID: 21670300 Free PMC article. No abstract available.
-
StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.PLoS One. 2013 Apr 8;8(4):e60969. doi: 10.1371/journal.pone.0060969. Print 2013. PLoS One. 2013. PMID: 23593359 Free PMC article.
References
-
- Schaffer AC, Lee JC. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents. 2008;32 (Suppl 1):S71–78. - PubMed
-
- Shinefield HR, Black S. Prospects for active and passive immunization against Staphylococcus aureus. Pediatr Infect Dis J. 2006;25:167–168. - PubMed
-
- Shinefield HR, Black S. Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev Vaccines. 2005;4:669–676. - PubMed
-
- Schaffer AC, Lee JC. Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am. 2009;23:153–171. - PubMed
-
- Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development. Expert Rev Vaccines. 2008;7:805–815. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
